Please search for your last name

no photo
Rigshospitalet
Department of Clinical Biochemistry
Institute for Molecular Medicine Finland
Human Genomics Unit
Kanazawa University
Department of Cardiology
CURRENT POSITION: Assistant Professor Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University EXPERIENCES: 2003 - 04 Resident in Medicine, Kanazawa University Hospital, Kanazawa, Japan 2004 - 05 Clinical Fellow in Cardiology and Internal Medicine Kouseiren Takaoka Hospital, Takaoka, Japan 2005 - 06 Clinical Fellow in Fukui Cardiovascular Center, Fukui, Japan 2006 - 10 Medical Staff in Division of Cardiovascular Medicine Kanazawa University Hospital, Kanazawa, Japan 2011 - 12 Assistant Professor Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan 2012 - 14 Research Scholar Massachusetts General Hospital Center for Human Genetic Research, Boston, MA, USA 2014 - Assistant Professor Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University Kanazawa, Japan
no photo
Kao corporation
Biological science research
no photo
Dr Reddy's laboratories
medical affairs
UC San Diego Medical Center
Cardiovascular Medicine
Pam R. Taub, MD, FACC, FASPC is a board-certified cardiologist and intentionally recognized expert in cardiometabolic disease. She is the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center and Professor of Medicine at UC San Diego. Dr. Taub was responsible for all aspects of creating the center, which provides a comprehensive cardiac rehabilitation program for patients with established heart disease. Her clinical practice focuses on preventive cardiology, cardiometabolic disease, lipidology, as well as women's cardiovascular health. Her research focuses on assessing the impact of behavioral, technological, and pharmacological interventions on cardiometabolic disease. Dr. Taub's is a federally funded researcher with funding from: the National Institutes of Health (Principal Investigator on R01 grant), Department of Defense, Department of Homeland Security and American Heart Association. She is an experienced clinical trialist and serves on the executive committee for multiple international clinical trials focused on novel cardiovascular therapies. Dr. Taub is widely published (with over 100 publications) and has authored high impact publications in top peer-reviewed journals including Cell Metabolism and the Journal of the American College of Cardiology that have made an impact on clinical practice. Dr. Taub holds multiple leadership positions in professional societies, serving as a fellow and board member for the American Society of Preventive Cardiology. She is a fellow and member of the American College of Cardiology Prevention of CV Disease Section Leadership Council. She also serves as the Vice-Chair of the American Heart Association Council Women in Cardiology Committee.
no photo
Radboud University Medical Centre
Department of Internal Medicine
University of Milan
Department of Pharmacological and Biomolecular Sciences
Ottavia Terenghi is a PhD student at the Department of Pharmacological and Biomolecular Sciences, at University of Milan, in the Laboratory of Lipoproteins, Immunity and Atherosclerosis, headed by Prof. G. D. Norata, where she is involved in several projects involving immunity and lipid metabolism.
no photo
Amsterdam University Medical Centres
Vascular Medicine
no photo
All India Institute of Medical Sciences
Biochemistry
no photo
University Medical Center Groningen
Pediatrics
As a Postdoctoral Researcher at UMCG, I have focused on investigating the molecular mechanisms underlying lipid metabolism by G protein-coupled receptor (GPCR) signaling. My work has involved using mouse models and in vitro approaches to study the role of orphan GPCRs in regulating cholesterol and triglyceride levels and identifying novel genes involved in lipid synthesis and metabolism. My experience in molecular biology techniques such as CRISPR/Cas9 and protein expression has allowed me to establish mouse models of fibrotic/cirrhotic liver diseases to investigate how histopathological changes and inflammatory microenvironment coordinate with the disease progression.
no photo
Örebro University
Cardiovascular research center
Klinisk Biokemisk Afdeling, Herlev og Gentofte Hospital
Department of Clinical Biochemistry
Peter E. Thomas is a medical doctor at the Department of Clinical Biochemistry at Copenhagen University Hospital, Herlev and Gentofte. His research is focused on lipoprotein(a) as a cause of cardiovascular disease.
The Chinese University of Hong Kong
School of Biomedical Sciences
Dr. Xiao-Yu TIAN is an Assistant Professor in the School of Biomedical Sciences, the Chinese University of Hong Kong since 2017. She got her PhD in Physiology in the Chinese University of Hong Kong, and finished her postdoctoral training in the UCSF. Her research interest is endothelial cell function, vascular homeostasis in atherosclerotic cardiovascular disease using mouse models. Her funding support mainly comes from Hong Kong Research Grant Council.
no photo
The Chinese University of Hong Kong
Department of Medicine and Therapeutics
Maastricht University Medical Center
Pathology
I am a PhD candidate mainly looking into macrophage and fibroblast function in atherosclerosis.
no photo
Faculty of Medicine, University of Belgrade
Institute of Medical Physiology "Richard Burian"
no photo
General University Hospital and First Faculty of Medicine, Charles University
III. INTERNAL CLINIC - ENDOCRINOLOGY AND METABOLISM
Hacettepe University Medical Faculty
Cardiology
S. Lale Tokgözoğlu, MD, FACC, FESC is Professor of Cardiology at Hacettepe University, Ankara, Turkey. She is currently the immediate Past-President of the European Atherosclerosis Society and Deputy Editor of the European Heart Journal. She chaired the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. Prof.  Tokgözoğlu has served on the Board of the Turkish Society of Cardiology and was elected to be the first female President of the Society in its history, between 2014-2016. During that time, she worked with the Ministry of Health to develop ‘Heart Health policies’ and strategies. She also chaired the Dyslipidaemia Working Group of the Turkish Society of Cardiology. She has contributed to several Guidelines and Consensus Papers on dyslipidaemia and Preventive Cardiology both in Europe and nationally. She was a member of the Steering Committee of the EUROASPIRE III-V studies which were the landmark studies defining preventive measures in Europe. She has also served on the Board of the Prevention Association as well as different committees of the European Society of Cardiology including the Fellowship and Training Committee, the Education Committee and currently the Research and Grants Committee. She is a member of the Science Academy and a founding member of the Atherosclerosis Research and Education Society in Turkey. She is also a founding member of the Department of Noncommunicable diseases in Hacettepe University. She serves on the Scientific and Research Council of Turkey Working Group on women researchers. Awards: Metrodora Award Global Leader in Science and Health 2020 Istanbul Medical Association Science Award in 2019 Paul Dudley White Science team award AHA 2017 Prof. Dr. Şeref Zileli Resident of the Year” Award in 1987 Young Investigator Award of the Turkish Society of Cardiology in 1994